4503:TYO
Astellas Pharma Inc
2 247,50 JP¥
arrow_downward
-0,02%(-0,50) 1D
9 қаз., 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4503...
Open
2 287 JP¥
High
2 288 JP¥
Low
2 232 JP¥
Mkt. cap
4,07 трлн
Avg. vol.
5,95 млн
Volume
5,90 млн
Dividend
3,47%
Quarterly dividend
20 JP¥
Ex-dividend date
2026 ж. 29 қыр.
P/E ratio
11,03
52-wk high
2 717 JP¥
52-wk low
1 558 JP¥
EPS
204 JP¥
Shares outstanding
1,92 млрд
No. of employees
14 мың
Open
2 287 JP¥
High
2 288 JP¥
Low
2 232 JP¥
Mkt. cap
4,07 трлн
Avg. vol.
5,95 млн
Volume
5,90 млн
Dividend
3,47%
Quarterly dividend
20 JP¥
Ex-dividend date
2026 ж. 29 қыр.
P/E ratio
11,03
52-wk high
2 717 JP¥
52-wk low
1 558 JP¥
EPS
204 JP¥
Shares outstanding
1,92 млрд
No. of employees
14 мың
News stories
From web sources and news partners
Business Wire
·
36 минут бұрын
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Yahoo Finance
·
1 сағат бұрын
UPDATED: TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq
GuruFocus
·
19 минут бұрын
Nasdaq CEO Flags Tens of Billions in New Wall Street Opportunity
Nasdaq
·
7 сағат бұрын
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees14,1 мың
Founded2005 ж. 01 сәу.
HeadquartersChuo City, Токио, Жапония
SectorPharmaceutical industry
Websiteastellas.com